Rekvina Laboratories Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
2.71 Cr.
|
P/BV
|
-8.17
|
Book Value (Rs.)
|
-0.55
|
52 Week High/Low (Rs.)
|
5/4
|
FV/ML
|
5/1
|
P/E(X)
|
0.00
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | -0.23 | -0.02 | 0.00 | -0.13 | -0.11 |
Diluted EPS (Rs.) | -0.23 | -0.02 | 0.00 | -0.13 | -0.11 |
Cash EPS (Rs.) | -0.22 | -0.02 | 0.00 | -0.13 | -0.10 |
Book Value[Excl.RevalReserv]/Share (Rs.) | -0.55 | -0.01 | 0.02 | 0.02 | 0.15 |
Book Value[Incl.RevalReserv]/Share (Rs.) | -0.55 | -0.01 | 0.02 | 0.02 | 0.15 |
PBDIT / Share (Rs.) | -0.22 | -0.02 | 0.00 | -0.12 | -0.10 |
PBIT / Share (Rs.) | -0.22 | -0.02 | 0.00 | -0.12 | -0.10 |
PBT / Share (Rs.) | -0.22 | -0.02 | 0.00 | -0.13 | -0.10 |
Net Profit / Share (Rs.) | -0.22 | -0.02 | 0.00 | -0.13 | -0.10 |
Return on Networth / Equity (%) | 0.00 | 0.00 | -5.65 | -566.88 | -69.18 |
Return on Capital Employeed (%) | 41.27 | 512.50 | -2.29 | -542.55 | -69.07 |
Return On Assets (%) | -421.84 | -8.13 | -0.36 | -41.02 | -26.45 |
Total Debt / Equity (X) | -0.74 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 0.08 | 0.04 | 0.05 | 0.00 | 0.06 |
Quick Ratio (X) | 0.08 | 0.04 | 0.05 | 0.00 | 0.06 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 0.00 | 0.00 | -0.68 | -22.30 | -641.00 |
Interest Coverage Ratio (Post Tax) (%) | 0.00 | 0.00 | -0.68 | -22.30 | -641.00 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 2.93 | 2.70 | 2.70 | 2.71 | 2.39 |
EV / EBITDA (X) | -21.40 | -164.82 | -8943.65 | -35.93 | -37.30 |
Price / BV (X) | -8.17 | -900.00 | 209.30 | 195.65 | 25.86 |
EarningsYield | -0.05 | -0.01 | 0.00 | -0.02 | -0.02 |